143 related articles for article (PubMed ID: 16767392)
1. Pegylated interferon-associated retinopathy in chronic hepatitis C patients.
Ogata H; Suzuki H; Shimizu K; Ishikawa H; Izumi N; Kurosaki M
Jpn J Ophthalmol; 2006; 50(3):293-5. PubMed ID: 16767392
[No Abstract] [Full Text] [Related]
2. [Pegylated-interferon-associated retinopathy].
Pérez-Alvarez MJ; Montes-Ramírez ML; Machín-Lázaro JM; Rodríguez-Zapata M
Enferm Infecc Microbiol Clin; 2007 Mar; 25(3):217. PubMed ID: 17335705
[No Abstract] [Full Text] [Related]
3. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
Burgueño-Montañés C; Pérez-Álvarez R
Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
[TBL] [Abstract][Full Text] [Related]
4. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
Kim ET; Kim LH; Lee JI; Chin HS
Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
[TBL] [Abstract][Full Text] [Related]
5. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ
Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
[No Abstract] [Full Text] [Related]
6. Black hairy tongue during interferon therapy for hepatitis C.
Arab JP; Vargas JI; Morales C; Arrese M
Ann Hepatol; 2015; 14(3):414-5. PubMed ID: 25864223
[No Abstract] [Full Text] [Related]
7. [Has hepatitis C become curable by a new pegylated interferon?].
Trépo C; Merle P
Presse Med; 2001 May; 30(18):905-8. PubMed ID: 11413851
[No Abstract] [Full Text] [Related]
8. Marked flare in hepatic aminotransferases during treatment with pegylated interferon for chronic hepatitis C, genotype 2: a case report.
Mishra P; DeVoss A; Pai R; Hart J; Jensen DM
Dig Dis Sci; 2009 Jun; 54(6):1369-72. PubMed ID: 18770036
[No Abstract] [Full Text] [Related]
9. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
[TBL] [Abstract][Full Text] [Related]
10. Interferon alfa, peginterferon alfa and retinopathy.
Prescrire Int; 2006 Apr; 15(82):61-2. PubMed ID: 16607695
[TBL] [Abstract][Full Text] [Related]
11. Erythema gyratum repens induced by pegylated interferon alfa for chronic hepatitis C.
Rongioletti F; Fausti V; Parodi A
Arch Dermatol; 2012 Oct; 148(10):1213-4. PubMed ID: 23069974
[No Abstract] [Full Text] [Related]
12. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferon associated lichen planus at the injection site.
Ergül B; Koçak E; Akbal E; Köklü S; Astarci HM
Acta Gastroenterol Belg; 2011 Dec; 74(4):591-2. PubMed ID: 22319976
[No Abstract] [Full Text] [Related]
14. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
15. [Diabetes mellitus during interferon therapy].
Tarabini-Castellani P; Apraiz L; Portu J; Agud JM
Enferm Infecc Microbiol Clin; 2008 Feb; 26(2):120-1. PubMed ID: 18341927
[No Abstract] [Full Text] [Related]
16. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
Papastergiou V; Skorda L; Lisgos P; Karatapanis S
Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
[No Abstract] [Full Text] [Related]
17. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
Bruch-Gerharz D; Reifenberger J
Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
[No Abstract] [Full Text] [Related]
18. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
Hu CC; Chien RN
Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
[No Abstract] [Full Text] [Related]
19. [Exceptional pancytopenia secondary to treatment with pegylated interferon and ribavirin].
Wikman Jorgensen PE; Jover Díaz FM; Cuadrado Pastor JM
Gastroenterol Hepatol; 2007 Apr; 30(4):253. PubMed ID: 17408558
[No Abstract] [Full Text] [Related]
20. Choreiform movements associated with pegylated interferon-alpha in a patient with chronic hepatitis C.
Akin M; İşler M; Şenol A; Kutluhan S; Tüfekçı A
Turk J Gastroenterol; 2012; 23(5):618-9. PubMed ID: 23161317
[No Abstract] [Full Text] [Related]
[Next] [New Search]